RARE Competitors & Alternatives
Compare Ultragenyx with similar stocks in the same industry
Biotechnology
RARE
Main Stock$33.22
Tradestie Score
62
Market Cap
$2.89B
Revenue Growth
0.0%
Analyst Upside
+57.5%
Top Competitors
229 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ADMA
ADMA Biologics, Inc.
|
$8.97
|
$3.59B | 13.4 | 61 | Compare |
|
ACAD
Acadia Pharmaceuticals Inc.
|
$25.50
|
$3.58B | 11.9 | 63 | Compare |
|
LGND
Ligand Pharmaceuticals Inc.
|
$309.25
|
$3.49B | 41.2 | 64 | Compare |
|
TLX
Telix Pharmaceuticals Limited American Depositary Shares
|
$10.97
|
$3.40B | - | 57 | Compare |
|
QURE
uniQure N.V.
|
$41.10
|
$3.39B | - | 61 | Compare |
|
SRRK
Scholar Rock Holding Corporation Common Stock
|
$54.70
|
$3.33B | - | 62 | Compare |
|
NAMS
NewAmsterdam Pharma Company N.V. Ordinary Shares
|
$33.28
|
$3.31B | - | 57 | Compare |
|
SLNO
Soleno Therapeutics, Inc. Common Stock
|
$53.01
|
$3.20B | 27.5 | 49 | Compare |
|
MLYS
Mineralys Therapeutics, Inc. Common Stock
|
$27.59
|
$3.09B | - | 58 | Compare |
|
VKTX
Viking Therapeutics, Inc
|
$38.12
|
$3.08B | - | 61 | Compare |
More RARE Analysis
Data updated: Jul 14, 2026 | Industry: Biotechnology (SIC 2834)
229 stocks in this industry